251 related articles for article (PubMed ID: 18330598)
41. Genomic Modifiers of Natural Killer Cells, Immune Responsiveness and Lymphoid Tissue Remodeling Together Increase Host Resistance to Viral Infection.
Gillespie AL; Teoh J; Lee H; Prince J; Stadnisky MD; Anderson M; Nash W; Rival C; Wei H; Gamache A; Farber CR; Tung K; Brown MG
PLoS Pathog; 2016 Feb; 12(2):e1005419. PubMed ID: 26845690
[TBL] [Abstract][Full Text] [Related]
42. CD8+ T cell evasion mandates CD4+ T cell control of chronic gamma-herpesvirus infection.
Tan CSE; Lawler C; Stevenson PG
PLoS Pathog; 2017 Apr; 13(4):e1006311. PubMed ID: 28394921
[TBL] [Abstract][Full Text] [Related]
43. The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence.
Campbell AE; Cavanaugh VJ; Slater JS
Med Microbiol Immunol; 2008 Jun; 197(2):205-13. PubMed ID: 18259775
[TBL] [Abstract][Full Text] [Related]
44. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
Jeitziner SM; Walton SM; Torti N; Oxenius A
Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
[TBL] [Abstract][Full Text] [Related]
45. Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection.
Beswick M; Pachnio A; Lauder SN; Sweet C; Moss PA
J Virol; 2013 Jan; 87(2):779-89. PubMed ID: 23115277
[TBL] [Abstract][Full Text] [Related]
46. Multiparametric analysis of host response to murine cytomegalovirus in MHC class I-disparate mice reveals primacy of Dk-licensed Ly49G2+ NK cells in viral control.
Prince J; Lundgren A; Stadnisky MD; Nash WT; Beeber A; Turner SD; Brown MG
J Immunol; 2013 Nov; 191(9):4709-19. PubMed ID: 24068668
[TBL] [Abstract][Full Text] [Related]
47. Phenotypic and functional characterization of CD8(+) T cell clones specific for a mouse cytomegalovirus epitope.
Fernandez JA; Zavala F; Tsuji M
Virology; 1999 Mar; 255(1):40-9. PubMed ID: 10049820
[TBL] [Abstract][Full Text] [Related]
48. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
[TBL] [Abstract][Full Text] [Related]
49. Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.
Lemmermann NA; Gergely K; Böhm V; Deegen P; Däubner T; Reddehase MJ
J Virol; 2010 Feb; 84(3):1221-36. PubMed ID: 19906905
[TBL] [Abstract][Full Text] [Related]
50. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.
Gold MC; Munks MW; Wagner M; Koszinowski UH; Hill AB; Fling SP
J Immunol; 2002 Jul; 169(1):359-65. PubMed ID: 12077265
[TBL] [Abstract][Full Text] [Related]
51. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
[TBL] [Abstract][Full Text] [Related]
52. Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.
Böhm V; Podlech J; Thomas D; Deegen P; Pahl-Seibert MF; Lemmermann NA; Grzimek NK; Oehrlein-Karpi SA; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2008 Jun; 197(2):135-44. PubMed ID: 18340461
[TBL] [Abstract][Full Text] [Related]
53. Caspase-8-dependent control of NK- and T cell responses during cytomegalovirus infection.
Feng Y; Daley-Bauer LP; Mocarski ES
Med Microbiol Immunol; 2019 Aug; 208(3-4):555-571. PubMed ID: 31098689
[TBL] [Abstract][Full Text] [Related]
54. Caspase-8 restricts antiviral CD8 T cell hyperaccumulation.
Feng Y; Daley-Bauer LP; Roback L; Guo H; Koehler HS; Potempa M; Lanier LL; Mocarski ES
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15170-15177. PubMed ID: 31285326
[TBL] [Abstract][Full Text] [Related]
55. Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity.
Stadnisky MD; Xie X; Coats ER; Bullock TN; Brown MG
Blood; 2011 May; 117(19):5133-41. PubMed ID: 21436069
[TBL] [Abstract][Full Text] [Related]
56. Down-regulation of MHC class I synthesis by murine cytomegalovirus occurs in immortalized but not primary fibroblasts.
Slater JS; Campbell AE
Virology; 1997 Mar; 229(1):221-7. PubMed ID: 9123864
[TBL] [Abstract][Full Text] [Related]
57. MCK2-mediated MCMV infection of macrophages and virus dissemination to the salivary gland depends on MHC class I molecules.
Bošnjak B; Henze E; Lueder Y; Do KTH; Rezalotfi A; Čuvalo B; Ritter C; Schimrock A; Willenzon S; Georgiev H; Fritz L; Galla M; Wagner K; Messerle M; Förster R
Cell Rep; 2023 Jun; 42(6):112597. PubMed ID: 37289588
[TBL] [Abstract][Full Text] [Related]
58. The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection.
Walton SM; Wyrsch P; Munks MW; Zimmermann A; Hengel H; Hill AB; Oxenius A
J Immunol; 2008 Jul; 181(2):1128-34. PubMed ID: 18606665
[TBL] [Abstract][Full Text] [Related]
59. Increasing inflationary T-cell responses following transient depletion of MCMV-specific memory T cells.
Sims S; Bolinger B; Klenerman P
Eur J Immunol; 2015 Jan; 45(1):113-8. PubMed ID: 25331015
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
